At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner ...

After six days in the hospital, Punturi was sent home with medicine, but on Sept. 8 as he was watching the Steelers beat the ...

The treatment was carried out in September 2024 at the National Heart Centre Singapore (NHCS), which treats cases of ...

we have a unique opportunity to evaluate tecarfarin in combination with the HeartMate 3™ LVAD, advancing our commitment to bringing forward the first innovation in vitamin K-targeted ...

Thanks to an organ donor, James Boyd of Newberry has a second chance at life. That’s also thanks to Sheila, his wife of over ...

The first clinical guidance for cardiogenic shock will be presented at the American College of Cardiology Scientific Session ...

Cadrenal Therapeutics has entered a partnership with Abbott for the tecarfarin anticoagulation and haemocompatibility with left ventricular assist devices (TECH-LVAD) trial. With Abbott’s ...

Veronica Even expected to bring her newborn, Theodore, home for Christmas. Instead, she watched as he was rushed to Manning ...

Placing an external ventricular drain (EVD) at bedside using augmented reality (AR) guidance is more precise than freehand placement and is associated with fewer reinterventions and ...

TX45 Phase 1b trial interim analysis demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in ...

A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, ...

Additional alignment with FDA on LX2006 planned pivotal study including protein expression co-primary endpoint: based on improvements in LVMI ...